J. Nutt, Continuous dopaminergic stimulation: Is it the answer to the motor complications of Levodopa?, Movement Disorders, vol.54, issue.1, pp.1-9, 2007.
DOI : 10.1002/mds.21060

O. Rascol, D. Brooks, A. Korczyn, D. Deyn, P. Clarke et al., A Five-Year Study of the Incidence of Dyskinesia in Patients with Early Parkinson's Disease Who Were Treated with Ropinirole or Levodopa, New England Journal of Medicine, vol.342, issue.20, pp.1484-91, 2000.
DOI : 10.1056/NEJM200005183422004

O. Rascol, D. Brooks, and E. Melamed, Rasagiline as an adjunct to levodopa in patients with Parkinson's disease and motor fluctuations (LARGO, Lasting effect in Adjunct therapy with Rasagiline Given Once daily, study): a randomised, double-blind, parallel-group trial, The Lancet, vol.365, issue.9463, pp.947-54, 2005.
DOI : 10.1016/S0140-6736(05)71083-7

C. Olanow, M. Stern, and K. Sethi, The scientific and clinical basis for the treatment of Parkinson disease (2009), Neurology, vol.72, issue.Issue 21, Supplement 4, pp.1-136, 2009.
DOI : 10.1212/WNL.0b013e3181a1d44c

R. Hauser, A. Hsu, and S. Kell, Extended-release carbidopa-levodopa (IPX066) compared with immediate-release carbidopa-levodopa in patients with Parkinson's disease and motor fl uctuations: a phase 3 randomised, double-blind trial, Lancet Neurol, vol.13, pp.1474-442270025, 2013.

R. Hauser, A. Ellenbogen, and L. Metman, Crossover comparison of IPX066 and a standard levodopa formulation in advanced Parkinson's disease, Movement Disorders, vol.5, issue.12, pp.2246-52, 2011.
DOI : 10.1002/mds.23861

O. Rascol, C. Goetz, W. Koller, W. Poewe, and C. Sampaio, Treatment interventions for Parkinson's disease: an evidence based assessment, The Lancet, vol.359, issue.9317, pp.1589-98
DOI : 10.1016/S0140-6736(02)08520-3

D. Weintraub, J. Koester, and M. Potenza, Impulse Control Disorders in Parkinson Disease, Archives of Neurology, vol.67, issue.5, pp.589-95, 2010.
DOI : 10.1001/archneurol.2010.65
URL : https://hal.archives-ouvertes.fr/hal-01306745

L. Seeberger and R. Hauser, Levodopa/carbidopa/entacapone in Parkinson???s disease, Expert Review of Neurotherapeutics, vol.9, issue.7, pp.929-969, 2009.
DOI : 10.1586/ern.09.64

F. Stocchi, O. Rascol, and K. Kieburtz, Initiating levodopa/carbidopa therapy with and without entacapone in early Parkinson disease: The STRIDE-PD study, Annals of Neurology, vol.24, issue.21 suppl 4, pp.18-27, 2010.
DOI : 10.1002/ana.22060

M. Coelho and J. Ferreira, Late-stage Parkinson disease, Nature Reviews Neurology, vol.351, pp.435-477, 2012.
DOI : 10.1038/nrneurol.2012.126